(UNCY) Unicycive Therapeutics - Performance 24.2% in 12m
UNCY performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.
Performance Rating
-45.18%
#63 in Peer-Group
Rel. Strength
72.33%
#2064 in Stock-Universe
Total Return 12m
24.20%
#41 in Peer-Group
Total Return 5y
-87.58%
#107 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | - |
| P/E Forward | - |
| High / Low | USD |
|---|---|
| 52 Week High | 9.00 USD |
| 52 Week Low | 2.36 USD |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 47.00 |
| Buy/Sell Signal +-5 | -2.74 |
| Support / Resistance | Levels |
|---|---|
| Support | |
| Resistance |
12m Total Return: UNCY (24.2%) vs XBI (-10.5%)
5y Drawdown (Underwater) Chart
Top Performer in Biotechnology
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| GILD NASDAQ Gilead Sciences |
-2.21% | 57.1% | 73.6% | 22.7 | 13.6 | 0.23 | 28.3% | -3.71% |
| UTHR NASDAQ United Therapeutics |
-9.17% | -10.4% | 138% | 12.9 | 12 | 1.43 | 74.6% | 16.1% |
| AMGN NASDAQ Amgen |
0.32% | -9.37% | 41.5% | 26.4 | 13.9 | 0.96 | 0.60% | 41% |
| BIM PA Biomerieux |
2.37% | 32% | 4.82% | 33.1 | 25.8 | 1.55 | -38.5% | -25.1% |
| KMDA NASDAQ Kamada |
13.1% | 60.1% | 5.41% | 25.5 | 22.8 | 0.91 | 48.1% | 3.93% |
| NBIX NASDAQ Neurocrine Biosciences |
4.19% | -5.4% | 1.82% | 42.4 | 24.4 | 0.27 | 18.7% | -34.3% |
| PTCT NASDAQ PTC Therapeutics |
2.15% | 39.1% | -3.46% | 7.71 | 6.26 | 0.81 | - | 68% |
| ERF PA Eurofins Scientific SE |
6.19% | 33.4% | 14.4% | 28.9 | 15.1 | 0.63 | -62.1% | -19.3% |
Performance Comparison: UNCY vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for UNCY
| Total Return (including Dividends) | UNCY | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 5.08% | 5.02% | 3.01% |
| 3 Months | -2.36% | -4.37% | 5.82% |
| 12 Months | 24.20% | -10.51% | 12.82% |
| 5 Years | -87.58% | -24.27% | 114.16% |
| Trend Score (consistency of price movement) | UNCY | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 20.3% | 48.6% | 78.3% |
| 3 Months | 49.6% | 46.4% | 87.1% |
| 12 Months | 69% | -82.8% | 43.5% |
| 5 Years | -64.3% | -52.9% | 84% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
|---|---|---|---|
| 1 Month | #93 | 0.06% | 2.01% |
| 3 Month | #95 | 2.10% | -7.72% |
| 12 Month | #41 | 38.79% | 10.08% |
| 5 Years | #98 | -80.37% | -91.55% |
FAQs
Does Unicycive Therapeutics (UNCY) outperform the market?
Yes,
over the last 12 months UNCY made 24.20%, while its related Sector, the SPDR S&P Biotech (XBI) made -10.51%.
Over the last 3 months UNCY made -2.36%, while XBI made -4.37%.
Performance Comparison UNCY vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
UNCY vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | -9% | 2.1% | -23% | 11% |
| US NASDAQ 100 | QQQ | -9.5% | 1.1% | -23.8% | 11% |
| German DAX 40 | DAX | -7.8% | 8.1% | -38.6% | -5% |
| Shanghai Shenzhen CSI 300 | CSI 300 | -10.6% | 0.8% | -23.5% | 5% |
| Hongkong Hang Seng | HSI | -11.4% | -3.1% | -42% | -11% |
| India NIFTY 50 | INDA | -9.3% | 4.2% | -24.7% | 24% |
| Brasil Bovespa | EWZ | -5.2% | 4.7% | -45% | 18% |
UNCY vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | -9% | 1.5% | -28.2% | 0% |
| Consumer Discretionary | XLY | -8.5% | 6.6% | -13% | 5% |
| Consumer Staples | XLP | -7.5% | 7% | -23.3% | 18% |
| Energy | XLE | -3.8% | 2% | -23% | 29% |
| Financial | XLF | -9.8% | 3.8% | -26.8% | -2% |
| Health Care | XLV | -8% | 3.3% | -18.1% | 31% |
| Industrial | XLI | -8.5% | 4.5% | -29.1% | 5% |
| Materials | XLB | -7.3% | 5% | -24.1% | 24% |
| Real Estate | XLRE | -6.5% | 4.4% | -23.8% | 12% |
| Technology | XLK | -10.4% | -2.5% | -25.3% | 13% |
| Utilities | XLU | -7.7% | 5.8% | -28.4% | 4% |
| Aerospace & Defense | XAR | -9.7% | 0.3% | -39.8% | -20% |
| Biotech | XBI | -7.8% | 0.1% | -11.3% | 35% |
| Homebuilder | XHB | -11% | 4.8% | -13% | 28% |
| Retail | XRT | -7.5% | 4.8% | -15.3% | 21% |
UNCY vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | 3.9% | -3.88% | -21.6% | 31% |
| Natural Gas | UNG | 5.3% | 12.2% | -24.5% | 41% |
| Gold | GLD | -6% | 4.2% | -47.7% | -19% |
| Silver | SLV | -6.3% | -4.1% | -43% | -1% |
| Copper | CPER | -8.7% | 1% | -40.6% | 11% |
UNCY vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | -8% | 2.6% | -22.8% | 28% |
| iShares High Yield Corp. Bond | HYG | -7.8% | 3.7% | -25.5% | 14% |